These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38911369)

  • 21. Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma: a bioinformatic analysis.
    Lai T; Li F; Xiang L; Liu Z; Li Q; Cao M; Sun J; Hu Y; Liu T; Liang J
    Transl Cancer Res; 2024 Sep; 13(9):4786-4799. PubMed ID: 39430830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
    Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
    PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients.
    Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z
    Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 25. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H
    Front Genet; 2021; 12():785185. PubMed ID: 34917132
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel prognostic model based on immunogenic cell death-related genes for improved risk stratification in hepatocellular carcinoma patients.
    Liu T; Chen X; Peng B; Liang C; Zhang H; Wang S
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10255-10267. PubMed ID: 37269346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
    Chen X; Sun M; Feng W; Chen J; Ji X; Xie M; Huang W; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Front Genet; 2023; 14():1056000. PubMed ID: 36845390
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.
    Liu Y; Meng J; Ruan X; Wei F; Zhang F; Qin X
    Sci Rep; 2024 Jan; 14(1):746. PubMed ID: 38185671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study.
    Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB
    Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic prediction and multidimensional dissections of a macrophages M0-related gene signature in liver cancer.
    Xu X; Wang J
    Front Endocrinol (Lausanne); 2023; 14():1153562. PubMed ID: 37033261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsin V is correlated with the prognosis and tumor microenvironment in liver cancer.
    Liu J; Zhang W; Wang Z; Wang Y; Li T; Wang Y; Ding J; Ning B
    Mol Carcinog; 2024 Mar; 63(3):400-416. PubMed ID: 38051285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma.
    Zhang C; Xu H; Sui X; Wu T; Chen B; Wang S; Wang X
    J Immunol Res; 2022; 2022():7073472. PubMed ID: 35983074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy.
    Cui Z; Liu C; Li H; Wang J; Li G
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38415454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and validation of a novel lysosome-related gene signature for predicting prognosis and immune landscape in hepatocellular carcinoma.
    Li H; Li J; Qu X; Dai H; Liu J; Ma M; Wang J; Dong W; Wang W
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17543-17557. PubMed ID: 37903936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.